A two-paragraph article in today’s NY Times, sans byline, appears to end discussion of the so-called “chemical signature” said to identify the source of water used to grow the anthrax letter spores: On Tuesday at an American Society for Microbiology conference in Baltimore, an F.B.I. scientist, Jason D. Bannan, said the water research ultimately was…
from an article by Debora MacKenzie, who has been knowledgeably reporting on anthrax and bioterrorism at the New Scientist for more than a decade: . . . Next the team developed highly sensitive tests to screen all 1072 samples for four of the mutations. Eight samples had all four. One came from a flask labelled…
Six spot-on suggestions from Steve Nissen, MD to the Obama administration.
Nature article by Roberta Kwok discusses the American Society for Microbiology’s Biodefense and Emerging Diseases Research Meeting in Baltimore, Maryland on February 24, 2009. Excerpt: Joseph Michael, a materials scientist at Sandia National Laboratories in Albuquerque, New Mexico, presented analyses of three letters sent to the New York Post and to the offices of Senators…
Merrill Goozner discusses a BMJ article by Nigel Hawke about Britain’s National Institute for Health and Clinical Excellence, and how it might help those of us in the less-regulated medical world to get useful information on pharmaceuticals. Excerpts: The global pharmaceutical industry considers Great Britain’s National Institute for Health and Clinical Excellence (NICE) about as…
Excerpts from Dr. Jon Abramson’s ABC News Op-Ed: It’s perfect. Pfizer buys Wyeth‘s pipeline, the behemoth marketing power of Pfizer gets leveraged, the work force gets consolidated and the $22 billion borrowed is read as a sign that banks are willing to lend again… The core problem with American medicine isn’t really access or cost….
End of content
End of content